"Designing Growth Strategies is in our DNA"
The global patient registry software market size was valued at USD 3.36 billion in 2024. The market is projected to grow from USD 3.78 billion in 2025 to USD 8.20 billion by 2032, exhibiting a CAGR of 12.20% during the forecast period.
Patient registry solutions support disease registries, product registries, and population health registries by collecting, managing, and analyzing structured patient data for research, public-health surveillance, clinical outcomes tracking, and post-market safety monitoring. It enables healthcare service providers, researchers, and public health agencies to track outcomes over time, generate evidence, and improve clinical care and operational decisions. This market is anticipated to witness strong growth in the near future, owing to the increasing usage of electronic health records, growing focus on real-world evidence (RWE), and increasing prevalence of chronic and rare diseases requiring long-term patient follow-up.
Furthermore, many key industry players, including IQVIA, Oracle, Veradigm LLC and others, are investing in innovative technologies to maintain their competitive edge.
Rising Adoption of Electronic Health Records (EHRs) and Interoperability Initiatives to Drive the Market Growth
The increasing adoption of electronic health records is anticipated to boost the global patient registry software market growth. As more healthcare providers integrate EHRs across departments, registries gain access to large volumes, real-time patient information. Additionally, owing to the mandatory interoperability standards, registry platforms can connect seamlessly with multiple data sources, driving the demand for automated, multi-site registries. This enables providers, researchers, and payers to generate stronger Real-World Evidence (RWE), improving clinical decision-making and population health management.
Integration Complexity with Legacy EHRs and Variability in Clinical Workflows to Restrict the Market Growth
Legacy EHR integration complexity and variable clinical workflows remain a major restraint limiting the adoption of patient-registry software across the world. Despite the advances in technology, several healthcare providers still rely on legacy Electronic Health Record (EHR) systems with proprietary, non-standard data models and limited interoperability. This results in difficulty in integrating a modern registry platform. Additionally, this also increases the overall cost of integration. As a result, data from legacy EHRs may be fragmented or incompatible, which hampers data exchange and prevents real-time registry updates.
Integration of AI and Machine Learning Offers Market Growth Opportunities
In recent years, the market for patient registry software has witnessed an increasing integration of artificial intelligence and machine learning technologies. This is due to the growing need for risk stratification, disease prediction, and Real-World Evidence (RWE) through advanced analytics. AI enables pattern recognition, automated data cleansing, and patient-segmentation, in turn reducing timelines, leading to increased efficiency.
Shift toward Cloud-based Registry Platforms is a Significant Trend Observed in the Market
The shift toward cloud-based registry platforms has become a prominent trend in the market in recent years. For the past few years, an increasing number of healthcare organizations have been shifting from on-premise infrastructure toward cloud-based platforms. This is driven by the increasing need for flexible access, scalability, lower upfront infrastructure costs, and improved data sharing across sites. Additionally, several advantages offered by cloud-based platforms also supported this trend among end users.
Data Privacy and Security Concerns Pose a Significant Challenge for the Market
Concerns associated with data security and privacy pose a significant challenge to the market for patient registry software. With the increasing adoption of these technologies in healthcare, highly sensitive health information of individuals is generated on a large scale, making it a prime target for cyberattacks. This elevates the risk of unauthorized access, breaches, or data misuse, in turn slowing down the market growth to a certain extent.
Download Free sample to learn more about this report.
Rising Burden of Chronic and Rare Diseases to Propel Disease Registry Segmental Growth
Based on the registry type, the market is divided into disease registry, health services registry, population registry, and others.
To know how our report can help streamline your business, Speak to Analyst
The disease registry segment dominated the market in 2024 with the largest market share. The dominance of the segment is attributed to rising burden of chronic and rare diseases, growing need for Real-World Evidence (RWE) studies, and others. Owing to these factors, many key companies are participating in strategic collaborations to launch innovative products and cater to increasing demand.
Moreover, the population registry segment is expected to grow at a CAGR of 11.10% during the forecast pe
Shift toward Value-based Care to Drive the Population Health Management Segmental Growth
Based on functionality, the market is segmented into population health management, medical research and clinical studies, health information exchange, patient care management, and others.
In 2024, the population health management segment held the largest global patient registry software market share based on functionality. The growth of this segment is driven by a shift toward value-based care, the increasing need to reduce patient readmissions, a large patient population, and the rising integration of AI in population health management. In addition, the rising adoption of PHM by end users also supplemented the market growth. Furthermore, the segment held a 36.1% share in 2025.
Additionally, the market for medical research and clinical studies is projected to grow at a CAGR of 11.13% during the study period.
High Patient Volume to Drive the Hospitals & ASCs Segmental Growth
Based on end user, the market is segmented into hospitals & ASCs, diagnostics centers, specialty clinics, and others.
In 2024, the market for patient registry software was primarily driven by hospitals & ASCs with the leading market share. Furthermore, this segment is estimated to capture a 54.3% share in 2025. Key factors supporting the dominance of the segment include high patient volume in these settings, increasing integration with EHR systems, and a growing focus on quality benchmarking and accreditation by hospitals. Additionally, collaborations between operating players and these end users further support the segment growth.
In addition, the diagnostic centers segment is projected to grow at a CAGR of 10.36% during the study period.
By geography, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominated the market in 2023, with a significant share of USD 1.30 billion, and maintained its leading position in 2024 at a value of USD 1.45 billion. The leading position of this region is driven by advanced healthcare IT infrastructure, high RWE adoption, and active registry programs in oncology, rare diseases, and cardiovascular care. Additionally, strategic initiatives by operating players in the region also drive growth further.
In 2025, the U.S. market is estimated to reach USD 1.32 billion.
Europe is expected to experience notable growth in the coming years. During the forecast period, the European region is projected to record a growth rate of 11.54%. It captured a valuation of USD 1.05 billion in 2025. The growth in the region is attributed to the strong public-health registry initiatives, emphasis on data privacy and standards, and growing RWE use in regulatory submissions. Backed by these factors, the U.K. recorded the valuation of USD 0.20 billion, Germany USD 0.21 billion, and France USD 0.17 billion in 2025.
The market for patient registry software in Asia Pacific reached a valuation of USD 2.01 billion in 2025 and secured the position of the third-largest region in the market. In the region, China and India captured a market value of USD 0.21 billion and USD 0.12 billion, respectively, in 2025. The growth in the Asia Pacific region is driven by rapidly developing healthcare infrastructure in India and China, coupled with the increasing penetration of advanced products in the region.
Over the forecast period, the Latin America and the Middle East & Africa regions are expected to witness significant growth in this market. The Latin America market is set to reach a valuation of USD 0.19 billion in 2025. The increasing adoption of advanced technologies in healthcare management is expected to drive market growth in these regions further. In the Middle East & Africa, the GCC captured a value of USD 0.06 billion in 2025.
Strategic Acquisitions and Collaborations by Key Players to Strengthen their Market Presence
The market for patient registry software reflects a moderately consolidated structure, comprising prominent players such as Oracle, IQVIA, Veradigm, Medical Information Technology, Inc., among others. The dominance of these companies can be attributed to factors such as strong investments in new product launches, extensive product portfolios, strategic acquisitions, and robust interoperability capabilities.
Other notable players in the global market include interActive Systems Berlin, RAYLYTIC Software GmbH, Access Healthcare, ScienceSoft USA Corporation, and others. These companies focus on new product launches, collaborations, and partnerships to increase their global market presence.
The market analysis provides a detailed study of the market size and forecast for all the market segments included in the report. The report also provides insights into market dynamics and trends expected to drive the market during the forecast period. The market report for patient registry software also comprises key aspects, such as an overview of technological advancements, product launches, insights on strategic partnerships, mergers and acquisitions, and key industry developments by top regions. The market forecast also provides a detailed competitive landscape, including market share and profiles of major industry players.
To gain extensive insights into the market, Download for Customization
| ATTRIBUTE | DETAILS |
| Study Period | 2019-2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Period | 2019-2023 |
| Growth Rate | CAGR of 12.20% from 2025-2032 |
| Unit | Value (USD Billion) |
| Segmentation | By Registry Type, Functionality, End User, and Region |
| By Registry Type |
|
| By Functionality |
|
| By End User |
|
| By Geography |
|
Fortune Business Insights states that the global market value stood at USD 3.36 billion in 2024 and is projected to reach USD 8.20 billion by 2032.
In 2024, the market value stood at USD 1.45 billion.
The market is expected to exhibit a CAGR of 12.20% during the forecast period of 2025-2032.
The disease registry segment led the market in terms of registry type in 2024.
Rising adoption of Electronic Health Records (EHRs) is one of the key factors driving the market.
Oracle, IQVIA, Veradigm, and Medical Information Technology, Inc., are among the major players in the global market.
North America dominated the market with the largest share in 2024.
Related Reports
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )